抽象的な

Clinical study ofHuxinkang tablet in treating unstable angina pectoris

Wang Guoqian, Yu Zhengke, Cheng Zhihong, Xie hongtu


To observe the clinical efficacy of Huxinkang Tablet on unstable angina pectoris (UAP). 65 patients ofUAPwere divided into the control group (32 cases) and treatment group (33 cases). All patients were treated with the westernmedicine. Then, patients in the control group and treatment group were administered Tongxinluo Capsule and HuxinkangTablet, respectively. The changes of clinical efficacy, angina pectoris (AP), electrocardiograph (ECG), Chinesemedicine syndrome (CMS), blood fat, homocysteine (Hcy) and high-sensitivity C-reactive protein (hs-CRP) of two groups were observed. Total effective rate of the treatment group was higher than the control group (P<0.05). The treatment group had a better curative effect of AP, ECGand CMS than the control group (P<0.05). HuxinkangTablet had better effects to improve lipid metabolismand lower the levels of Hcy and hs-CRP than the control group (P<0.05). It is effective that the clinical efficacy of Huxinkang Tablet in treating UAP.


インデックス付き

  • キャス
  • Google スカラー
  • Jゲートを開く
  • 中国国家知識基盤 (CNKI)
  • サイテファクター
  • コスモスIF
  • 研究ジャーナル索引作成ディレクトリ (DRJI)
  • 秘密検索エンジン研究所
  • ユーロパブ
  • ICMJE

もっと見る

ジャーナルISSN

ジャーナル h-インデックス

Flyer

オープンアクセスジャーナル